Dr Walkiria Schlindwein

Dr Schlindwein graduated as Chemical Engineer in 1984 from the Federal University of Rio de Janeiro, UFRJ, Brazil. She obtained her M.Sc. in Polymer Science and Technology from the Institute of Macromolecules of the UFRJ, Brazil in 1986, PhD in Chemistry from the Department of Chemistry of the University of Leicester, England, in 1990, and DSc in Chemistry from the UFRJ in 1992. 

• Pharmaceutical Technologies

Click here to view a full listing of Walkiria Schlindwein's publications and outputs.

• Quality by Design
• Dissolution
• X-ray spectroscopy
• Cocrystals
• Granulation

Her current research interests are in the areas of material sciences with particular interest in polymers used in pharmaceutical applications. She collaborates with Dr Mingzhong Li and supervises PhD students in the areas of formulation of poorly soluble drugs and dissolution studies using flow through cells, USP IV and Surface Imaging techniques.

More recently, she was involved with the validation and implementation of two Postgraduate courses, a full time MSc in Pharmaceutical Quality by Design and an online flexible learning MSc in Quality by Design for the Pharmaceutical Industry.  The latter was the result of a unique collaboration between De Montfort University and more than 50 industrialists from 22 companies including AstraZeneca, GlaxoSmithKline, Pfizer and Bristol-Myers Squibb.

• Quality by Design Principles and Tools
• Pharmaceutical Materials Sciences
• Pharmaceutical Processes and Technologies
• Product Formulation
• Pharmaceutical Product Development and Manufacture

• PhD, MSc, ChemEng

•  BSc Pharmaceutical and Cosmetic Science,

•  Full time MSc Pharmaceutical Quality by Design,

•  Distance learning in MSc Quality by Design for the Pharmaceutical Industry

• Member of the UK Biomaterials Network

•  Member of the Academy of Pharmaceutical Sciences

•  Member of the European Federation of Pharmaceutical Sciences

APS Materials Science, 13-14 May 2013, EMCC, Nottingham, invited presentation: Introduction to Qbd Concepts.

Quality by Design Approaches to Pharmaceutical Product & Process Development.

• Miss Ning Qiao, PhD, 2^nd supervisor
• Mr Huolong Liu, PhD, 2^nd supervisor
• Miss Shi Qiu, PhD, 2^nd supervisor
• Mr Yan Lu, PhD, 2^nd supervisor
• Ms Tayseer Kabsoun, MSc, 1^st supervisor

• Quality by Design, ERDF, £100K, 2010-2011

• Pharmaceutical Quality by Design, HEIF5, £71720 Aug 2011 - Jul 2013, PI